Structure (Bumetanide Tablets 1)
Bumetanide Tablet
Product Images NDC 0904-7016
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bumetanide (NDC 0904-7016). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
D0a07b46 30f7 4e35 9995 B060d8c397c9 00
This is a medication package for Bumetanide, containing 30 tablets of the medication in unit dose packaging. The medication is a prescription drug and should only be taken under medical supervision. The usual dosage instructions can be found in the product insert, which can be accessed online. It should be stored at temperatures between 20°C to 25°C and kept away from the reach of children. The package is not child-resistant and can only be used in institutions. The package was manufactured by Ammes Pharmaceuticals in India and distributed by Major Pharmaceuticals in Livonia, MI, USA.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
